About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Relapse Rate of C. Diff Infection Reduced by Drug

by Kathy Jones on February 3, 2011 at 8:28 PM
Font : A-A+

 Relapse Rate of C. Diff Infection Reduced by Drug

A study has revealed that a new antibiotic has been shown to cut the rate of relapse by almost half of infections of the C. difficile bacterium, a growing scourge in hospitals worldwide.

The researchers examined a drug called Fidaxomicin, made by Optimer Pharmaceuticals of San Diego, and compared it to the antibiotic vancomycin, the only treatment against the infection approved in the United States and Canada.

Advertisement

By following 629 subjects over two years in a randomized study in which patients received one of the two treatments, those who took Fidaxomicin saw a 45 percent reduction in recurrences.

"Anybody who knows C. difficile recognizes that recurrences are the major problem with this disease," said Mark Miller of the Jewish General Hospital in Montreal, a co-author of the study in the New England Journal of Medicine.
Advertisement

"Anything that can reduce the recurrence rate, especially as dramatically as Fidaxomicin, is a very important milestone in the treatment of C. difficile."

C. difficile, which can cause anything from mild diarrhea to deadly colon inflammation, tends to afflict people in hospitals or long-term care facilities and can take hold after a patient has been on antibiotics.

Cases have been mounting in the past decade and 20 to 30 percent of patients who suffer from it once will get it again. Recurrent C diff is particularly hard to treat.

"There wasn't much interest in C. difficile for many years, because it wasn't considered a serious disease," said Miller.

"However, over the past decade the bacterium has mutated into something much more serious that has caused epidemics worldwide. It is particularly notorious for recurrences."

Fidaxomicin works by targeting bacteria inside the intestine and is minimally absorbed in the blood stream, so it kills the C. diff "without affecting the beneficial flora in the human gut which help stave off recurrences," the study said.

Source: AFP
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Alarming Cesarean Section Trends in India - Convenience or Compulsion of Corporate Healthcare
Quiz on Low-Calorie Diet for Diabetes
World Heart Day in 2022- Use Heart for Every Heart
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Signature Drug Toxicity Flu 

Most Popular on Medindia

Loram (2 mg) (Lorazepam) Drug - Food Interactions Nutam (400mg) (Piracetam) Diaphragmatic Hernia Selfie Addiction Calculator Color Blindness Calculator Vent Forte (Theophylline) Post-Nasal Drip How to Reduce School Bag Weight - Simple Tips Find a Hospital
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

Relapse Rate of C. Diff Infection Reduced by Drug Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests